Cleared Traditional

K122202 - ELLEX 2RT

K122202 is an FDA 510(k) clearance for ELLEX 2RT, manufactured by Ellex Medical Pty, Ltd.. The device is a Class 2 Ophthalmic device with product code HQF cleared through the Traditional 510(k) pathway after a 341-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2013
Decision
341d
Days
Class 2
Risk

K122202 is an FDA 510(k) clearance for the ELLEX 2RT. Classified as Laser, Ophthalmic (product code HQF), Class II - Special Controls.

Submitted by Ellex Medical Pty, Ltd. (Adelaide, South Australia, AU). The FDA issued a Cleared decision on July 1, 2013 after a review of 341 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4390 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Ellex Medical Pty, Ltd. devices

FDA 510(k) Submission Details - K122202

510(k) Number K122202 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 25, 2012
Decision Date July 01, 2013
Days to Decision 341 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
231d slower than avg
Panel avg: 110d · This submission: 341d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQF Device Classification - Class 2, Special Controls

Product Code HQF Laser, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4390
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQF Laser, Ophthalmic

All 85
Devices cleared under the same product code (HQF) and FDA review panel - the closest regulatory comparables to K122202.
OPTIMUS FUSION: SLT, YAG AND YAG/SLT
K140336 · Quantel Medical · Jun 2014
SCANNING LASERLINK
K130195 · Lumenis, Inc. · Nov 2013
SOLUTIS
K130933 · Quantel Medical · Aug 2013
SUPRA SCAN DELIVERY SYSTEM
K120825 · Quantel Medical · Sep 2012
VISULAS TRION LASER SYSTEM WITH THE VITE OPTION
K103056 · Carl Zeiss Meditec, AG · Feb 2011
VISUMAX LASER KERATOME
K100253 · Carl Zeiss Meditec, AG · Jul 2010